Business

Burger King, Tim Hortons Parent Restaurant Brands Sees Slowing First-Quarter Comparable Sales

Burger King, Tim Hortons Parent Restaurant Brands Sees Slowing First-Quarter Comparable Sales

Restaurant Brands International (QSR) reported slowing comparable-store sales across its Burger King, Tim Hortons and Popeyes chains on Monday as the company’s first-quarter results came in mixed. Total revenue rose to $1.27 billion from $1.25 billion in the same period of 2018, in line with the consensus on Capital IQ. But adjusted earnings fell to $0.55 per share from $0.66 […]

Wall Street Wavers as Jam-Packed Week of Earnings, Data Starts

Wall Street Wavers as Jam-Packed Week of Earnings, Data Starts

US stocks were struggling for a direction ahead of Monday’s opening bell as traders braced for another heavy week of corporate earnings and economic data. Oil prices nudged lower with global benchmark Brent crude down 0.26%, and US West Texas Intermediate crude off 0.32%, extending Friday’s sell-off after President Donald Trump said he asked the Organization of the Petroleum Exporting […]

Pinterest, Zoom Video Surge in Trading Debuts After Tech Firms Price IPOs Ahead of Expectations

Pinterest (PINS) and Zoom Video Communications (ZM) both saw their shares rally in trading debuts on Thursday, surging above their initial public offering prices. Pinterest ended up 28% on the New York Stock Exchange after the social-media site for sharing ideas about cooking, crafts, home decor and fashion priced its IPO at $19 a share. That’s up from the $15 […]

Stocks Rise on Solid Earnings Reports, Retail Sales Data

Equities rose Thursday as shares were bolstered by a number of solid earnings reports and retail sales that topped expectations. Sectors in the Standard & Poor’s 500 Index were led by industrials, which rose 1%. The sector was boosted by Union Pacific (UNP) as the railroad operator jumped more than 4.4% after its first-quarter earnings beat expectations. Honeywell (HON) also […]

Pfizer, Eli Lilly Plan to Consult with Regulator on Tanezumab for Osteoarthritis

Pfizer (PFE) and Eli Lilly (LLY) said on Thursday top-line results from its late-stage trial of tanezumab in patients with osteoarthritis showed mixed results and would consult with regulator over the next steps. “We are analyzing these findings in the context of the recent Phase 3 results as we assess potential next steps for tanezumab,” said Ken Verburg, Pfizer Global […]